FDA regulated clinical research study for presbyopia

Wang Vision Institute is conducting a US FDA regulated clinical research study on a new investigational eye surgery, scleral spacing procedure (SSP), to correct age-related loss of near vision (presbyopia). SSP is an out-patient procedure in which a surgeon creates a new space near the ciliary muscle, to possibly allow a more efficient contraction of the lens and muscles, to achieve better reading.

SSP Seminar Agenda:

1. Description of presbyopia and theories behind it.
2. Brief explanation of the surgical procedure and the intent of the surgery
3. Discuss the length of the study, expectations from the subjects (required visits, consent, commitment to the study)
4. Inform of initial requirements to become potential candidate
   1. In good general health
   2. No previous eye surgeries
   3. Between the ages of 50-60 years of age
   4. No distance prescription (Need reading glasses only)
5. Question and answer period with Dr. Wang and current subjects who have had the surgery.
6. Subject interested in more information and interested in pursuing the screening process are instructed to contact the study coordinator via e-mail.

	WNDU.com South Bend, IN, reporting of Dr Ming Wang's FDA Clinical trial on presbyopia treatment
	WREG reporting of Dr Wang Performs Surgery for FDA Prespyopia Clinial Trial Studies
	"Presbyopia surgery to reduce reading glasses need", Nashville, TN The Tennessean, 12/14/09, reported by Christina Sanchez, staff writer
	"Age Related Eye Loss Study In Nashville", Video Report of FDA Presbyopia Clinical Trial at Wang Vision Institute from Fox 17, by -Erika Lathon
	WKRN/ABC reporting of Dr Ming Wang Performs Surgery for FDA Clinical Research Study
	"Nashville Among 3 Cities In FDA Eye Surgery Trial", a report from WSMV/NBC. Click here to watch videos.
	WTVF/CBS Ch5 reporting of Dr Wang Performs SSP Surgery for FDA Clinial Trial Studies